These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20109414)

  • 1. Sex does not influence prognosis in diabetic patients. The Barbanza Diabetes study.
    Vidal-Pérez R; Otero-Raviña F; Grigorian-Shamagian L; Parga-García V; Eirís-Cambre MJ; de Frutos-de Marcos C; Caneda-Villar C; de la Fuente-Mariño R; Ramos-González A; González-Juanatey JR;
    Rev Esp Cardiol; 2010 Feb; 63(2):170-80. PubMed ID: 20109414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the location of previous atherosclerotic disease on prognosis in diabetic patients. The Barbanza Diabetes Study].
    González-Juanatey JR; Grigorian-Shamagian L; Juiz-Crespo MA; Sánchez-Loureiro M; Rodríguez-Moldes E; Dopico-Pita J; Gutiérrez-Fernández G; Torres-Colomer J; Blanco-Rodríguez R; Otero-Raviña F;
    Rev Esp Cardiol; 2008 Nov; 61(11):1168-77. PubMed ID: 19000492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.
    So WY; Ozaki R; Chan NN; Tong PC; Ho CS; Lam CW; Ko GT; Chow CC; Chan WB; Ma RC; Chan JC
    Hypertension; 2004 Sep; 44(3):294-9. PubMed ID: 15249544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality risk remains higher in individuals with type 1 diabetes: A population-based cohort study (the Ayrshire diabetes follow-up cohort [ADOC]).
    Collier A; Connelly PJ; Hair M; Cameron L; Ghosh S; Waugh N
    Diabetes Obes Metab; 2018 Aug; 20(8):1965-1971. PubMed ID: 29687581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum 25(OH)D
    Samefors M; Scragg R; Länne T; Nyström FH; Östgren CJ
    Diabet Med; 2017 Mar; 34(3):372-379. PubMed ID: 27862247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Anderson RE; Pfeffer MA; Thune JJ; McMurray JJ; Califf RM; Velazquez E; White HD; Rouleau JL; Skali H; Maggioni A; Solomon SD
    Am Heart J; 2008 Apr; 155(4):706-11. PubMed ID: 18371480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial.
    Cice G; Di Benedetto A; D'Isa S; D'Andrea A; Marcelli D; Gatti E; Calabrò R
    J Am Coll Cardiol; 2010 Nov; 56(21):1701-8. PubMed ID: 21070920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study.
    Wolde HF; Atsedeweyen A; Jember A; Awoke T; Mequanent M; Tsegaye AT; Alemu S
    BMC Endocr Disord; 2018 Jul; 18(1):52. PubMed ID: 30064436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.
    Böger CA; Haak T; Götz AK; Christ J; Ruff E; Hoffmann U; Riegger GA; Krämer BK
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):364-74. PubMed ID: 16961167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.
    J Hypertens; 1993 Mar; 11(3):309-17. PubMed ID: 8387089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
    Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK
    J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild renal insufficiency as a cardiovascular risk factor in non-proteinuric type II diabetes.
    Gimeno-Orna JA; Lou-Arnal LM; Boned-Juliani B; Molinero-Herguedas E
    Diabetes Res Clin Pract; 2004 Jun; 64(3):191-9. PubMed ID: 15126007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.